endo-Fenchol is a bicyclic monoterpene alcohol found in a narrower set of aromatic oils than more common terpene alcohols, but it can dominate certain profiles such as leleshwa or camphor bush. The evidence base is solid for identity, stereochemistry, fragrance use, and repeated occurrence in essential-oil chemistry. Direct bioactivity literature exists and includes antibacterial screening, larvicidal work, and a recent FFAR2-linked neuroprotection paper, but those findings are still preclinical and should not be translated into medical claims.
Chemical identity and composition
PubChem maps `endo-Fenchol` to the stereospecific `(-)-alpha-Fenchol` record with formula C10H18O and InChIKey IAIHUHQCLTYTSF-MRTMQBJTSA-N. Public registries split fenchol across stereoisomers and sometimes attach different CAS numbers to generic or enantiomer-specific names; this record follows the explicit endo or (-)-alpha-fenchol PubChem synonym set, which includes CAS 512-13-0, while noting that supplier or oil records may also use other alpha-fenchol CAS numbers for alternate stereochemical records. In the archive, leleshwa or camphor bush currently treats endo-fenchol as a lead constituent at 21.2%.
Aroma and practical use
- Use the recorded camphoraceous, piney, herbal, fresh woody, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2021 FFAR2 paper reported that fenchol acted as a potential FFAR2 stimulator and reduced amyloid-beta accumulation and related neurodegenerative phenotypes in neuronal cells, C. elegans, and mice models.
This is a mechanistically interesting preclinical result, but it does not establish human neurological benefit and should remain clearly nonclinical.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2007 screening study of 21 oxygenated monoterpenes found that fenchol showed broad-spectrum antibacterial activity across the tested bacterial panel, although its activity was still weaker than penicillin.
This provides direct constituent-level antimicrobial support, but the method was a simple in vitro screening assay.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2020 study on Dizygostemon riparius essential oil reported that the fenchol standard showed dose-dependent larvicidal activity, reaching 98% mortality at 900 mg/L in the assay system used.
This is useful as a direct constituent assay, but it is an insect-control model rather than a human-use finding.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedA 2008 fragrance material review indicates that a toxicologic and dermatologic review exists for fenchyl alcohol as a fragrance ingredient, which is stronger safety support than many minor archive terpenes have.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The accessible Good Scents page for (+)-alpha-fenchol reports no GHS hazards found on-page, but that page maps to a different stereochemical record than the (-)-endo-fenchol identity used here.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No constituent-specific IFRA maximum or human topical trial for isolated endo-fenchol was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
ffar2_agonist_signaling
A 2021 mechanistic study identified fenchol as a natural FFAR2 agonist and linked FFAR2 activation to increased proteolytic amyloid-beta clearance and reduced neuronal senescence in preclinical models.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Public nomenclature is messy: endo-fenchol, alpha-fenchol, and fenchyl alcohol pages often point to different stereoisomer-specific CAS numbers.
- Most direct bioactivity evidence is preclinical and often not clearly separated by enantiomer in summaries.
- No verified standalone dermal-use limit for isolated endo-fenchol was located in this pass.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.